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Many changes have occured in obstetrics during the past
decade and a half. Many different technologies aimed at
reducing perinatal morbidity and mortality have been in-
troduced which have changed the manner in which obstetrics
is practiced. At the Sloane Hospital for Women (Columbia
University) the perinatal mortality rate has been reduced
from 25 to <10 (1000 livebirths, 1000 gras & 28 days);
virtually all intrapartum patients are monitored elec-
tronically and 25% undergo acid-base monitoring with al-
most total elimination of intrapartum stillbirths and a
reduction of morbid Apgar scores (^6) to 10% & 1.1% at l
and 5 minutes. The primary caesarean section rate has
climbed to 14% (total=23%), but the incidence of fetal
distress äs a cause for a primary caesarean section has
dropped to 11% while the percentage performed for cepha-
lopelvic disproportion remained unchanged ( 3 3 % ) . Although
antepartum (AP) fetal monitoring is used in ± 15% of AP
patients (high risk), the AP stillbirth rate of O.5% re-
presents almost 100% of all fetal losses (1).
Although AP fetal surveillance utilizes estriol determin-
ations, amnioscopy, evaluation of fetal activity, real-
time/static ultrasound, the majority of AP fetal surveil-
lance is by the fetal heart rate test (APFHRT). The pri-
mary screening APFHRT is the nonstress test (NST). Ab-
dominal wall fetal EGG ( 8 0 % ) , phonocardiography (10%) ,
and ultrasound (10%) are used. Four fetal movements in
a 20 minute interval that are noted with FHR accelerations
of > 15 seconds and a maximal amplltude of > 15 bpm are
referred to äs a reactive test indicating a fetus with. an
intact neurocardiovascular Integration ( 2 ) . Approximately
90% of all NSTs are reative during the first 20 minute
interval or following manual Stimulation in the second
20 minute interval. Occasionally the nonreactive NST is
repeated after a meal and ambulation or even within 24
hours, and 90% of these NSTs become reactive. Usually a
nonreactive NST is followed by a contraction stress test
(CST) evaluating fetal respiratory reserve. A negative
CST—no late decelerations with 3 oxytocin induced or
spontaneous contractions in a 10 minute interval—and a
reactive NST both are indicative of a healthy fetus and
a high probability of good fetal condition for a week un-
less the maternal condition changes. The NST may be a
slightly better indicator of well-being than the CST (3)
A positive CST-- late decelerations'with each of the 3
uterine contractions in a 10 minute interval—is an in-
dicator of loss of fetal well-being; however, 25 to 50+%
of these fetuses tolerate a well monitored induction of
labor ( 4 ) . Thus, in the absence of pulmonary maturity, a
positive CST is generally substantiated by a low or fall-
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estriol value before initiating a delivery process al-
though pharroacologic induction of pulraonary maturity may
be considered before Initiation of a delivery process.
The use of APFHRT is expanding froro the very high risk
to the lower risk and normal patients. Intensive eval-
uation of these tests indicate that additional informa-
tion inay be obtained froin them such äs the liklihood of
abnormal cord position or intrapartum cord complications
when variable decelerations are noted with fetal inovements
during an NST (5,6) . The use of APFHRT for the improve-
ment in soine AP conditions such äs sinusoidal patterns
or postdatism are just now being evaluated (7) . It is
expected that additional evaluation of these tests will
offer more insight into other pathologic states.
The NST-CST form of APFHRT will probably remain the cor-
norstone of AP fetal surveillance for well-being in the
1980's; however, if a significant reduction in AP still-
birth rate is to be achievedf it is inandatory that a great-
er portion of the AP Population be tested, and the pre-
cision for identification of the fetus who is truly at
risk of damage or death in utero must be improved. Some
of the techniques for ineeting these mandates appear to
be already available to the obstetrician. The extension
of the testing protocol and the improvement in predictive
ability may be achieved by the evaluation of fetal activ-
ity on a inore formal basis in all AP patients from 28 to
30 weeks gestation to delivery (8,9) and by the use of
real-time ultrasound to evaluate additional fetal features
including breathing, trunk and limb motion, amniotic
fluid volume (10). Electromechanical intervals and urine
production (11, 12) can be used with some simplification
and refinement of these techniques.
It is relatively easy and inexpensive to instruct all
patients to count fetal movements and record them. If
a patient notes inadequate fetal moveinent, this patient
can be included easily with those high risk patients who
are undergoing APFHRT without adding undue strain on the
testing systein. Tests of fetal activity have the added
advantage of being able to be used by patients already
receiving APFHRT äs a backup should the maternal medical
condition undergo an unrecognized change and thus inval-
id ate the predictive value of a reactive or negative
APFHRT.
Current precision at the 'identification of the fetus
in good condition is adequate (99+%); however, high
false positive CST and false nonreactive NST rates indi~
cate that qreater precision is needed for the identi-
fication of the unhealthy fetus. This will probably re-
quire additional teäts. The test of a profile of fetal
functions and amniotic fluid volume is already in early
use. It appears that the appropriate evaluation of
other fetal functions and measurements will add sig-
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nificantly to the ability of the obstetrician to more ac-
curately identify the truly distressed fetus. These eval-
uations will be performed following a nonreactive NST or
a positive CST. It is expected that the currently de-
scribed tests (10) can reduce the false indication of
loss of fetal well-being to 10% within a few years. It
is expected that additional tests will be available with-
in this decade to improve the AP diagnostic ability
even more.
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